跳至主要内容
临床试验/NCT04731285
NCT04731285已完成不适用

Accuracy of RuiXin-FFR by Comparing With Pressure-wire-based FFR in Detecting Hemodynamically Significant Stenosis: A Prospective Multicenter Study

Beijing Anzhen Hospital1 个研究点 分布在 1 个国家目标入组 316 人开始时间: 2019年3月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
316
试验地点
1
主要终点
Sensitivity and Specificity

研究概览

简要总结

Coronary Artery Disease (CAD) is the top killer nowadays. Pressure-wire-based Fractional Flow Reserve (FFR) is the gold standard for measuring ischemia in coronary arteries. CFD-based RuiXin-FFR, which is noninvasive, is developed recently. But its accuracy is not verified. This is a multi-center and prospective study to evaluate the sensitivity, specificity, and accuracy of CFD-based RuiXin-FFR compared with wire-based FFR.

详细描述

The participants are entered with suspended CAD and angiography ischemia between 30%-90% from 6 hospitals in China. Pressure-wire-based FFR is conducted in the standard protocol by each hospital. FFR>0.8 is chosen as the threshold to indicate non-ischemia. CFD-based RuiXin-FFR is performed by Raysight Medical (Shenzhen, China). CT images are acquired in a standard protocol by each hospital. Images with poor quality are excluded in this trial. Based on these images, RuiXin-FFR reconstructs the 3D model of coronary trees and obtains RuiXin-FFR values by conducting CFD simulations in a blinded fashion. RuiXin-FFR>0.8 is chosen as the threshold to indicate non-ischemia as well. By comparing the clinical diagnosis outcome of pressure-wire-based FFR and CFD-based RuiXin-FFR, the sensitivity and specificity of the RuiXin-FFR are obtained, which is the primary end point of this trial. The secondary end point includes the measurement of accuracy, NPV, PPV and ROC of the RuiXin-FFR.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • able to understand the purpose of the study and sign the informed consent
  • with diagnosed or confirmed coronary artery disease according to the comprehensive clinical assessment
  • with CTA image indicating that the diameter of the reference vessel in the stenosis segment was ≥2mm
  • with CTA image indicating that the stenosis degree of coronary artery lumen diameter ≥30% and ≤90%

排除标准

  • prior coronary artery bypass bypass (CABG) surgery, coronary interventional therapy (PCI), artificial heart valve implantation, cardiac pacemaker or implantable defibrillator implantation
  • persistent or active symptoms of clinical instability, including acute chest pain (sudden onset), cardiogenic shock, unstable blood pressure status (systolic pressure less than 90 mmHg), severe congestive heart failure (NYHA grade III or IV), or acute pulmonary edema
  • acute myocardial infarction occurred within 7 days before inclusion
  • complex congenital heart disease, sick sinus syndrome, long QT syndrome, severe arrhythmia, tachycardia, severe asthma, severe or very severe chronic obstructive pulmonary disease (COPD) and chronic renal damage (serum creatinine value > 1.5 mg/dl or creatinine clearance < 45 ml/Kg*1.73 m2)
  • there are contraindications for the use of adenosine disodium triphosphate
  • allergic to iodized contrast media
  • pregnancy or pregnancy status unknown
  • life expectancy less than 2 months
  • there are any factors that other researchers consider not suitable for inclusion or completion of this study
  • obvious mismatch of coronary artery CTA images
  • CTA image showing calcification occupies the cross-sectional area of the lumen > 80%
  • CT value standard deviation of aortic root image >30HU
  • coronary artery occlusion.

结局指标

主要结局

Sensitivity and Specificity

时间窗: 9 days

By comparing with pressure-wire-based FFR, the sensitivity and specificity of CFD-based RuiXin-FFR are measured

次要结局

未报告次要终点

研究者

发起方
Beijing Anzhen Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Shao-Ping Nie

Professor

Beijing Anzhen Hospital

研究点 (1)

Loading locations...

相似试验